Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

OBJECTIVE: Our purpose was to characterize distinct molecular subtypes of diffuse large B cell lymphoma (DLBCL) patients treated with rituximab-CHOP (R-CHOP). METHODS: Two gene expression datasets of R-CHOP-treated DLBCL patients were downloaded from GSE10846 (n = 233, training set) and GSE31312 (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Haifeng, Peng, Shuailing, Han, Shuiyun, Chen, Xi, Lyu, Qinghua, Lei, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238567/
https://www.ncbi.nlm.nih.gov/pubmed/34250086
http://dx.doi.org/10.1155/2021/5514726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238567/
https://www.ncbi.nlm.nih.gov/pubmed/34250086
http://dx.doi.org/10.1155/2021/5514726

Ejemplares similares